The Food and Drug Administration’s independent advisors voted to recommend Moderna’s COVID-19 vaccine for children and teens between 12 and 17. On Wednesday, the same committee is scheduled to vote on whether to recommend emergency authorization of both the Moderna and Pfizer-BioNTech vaccines for the nation’s youngest children. (The New York Times

The World Health Organization is considering a new name and emergency designation for monkeypox. Last week, more than two dozen scientists pressed WHO about the “urgent need for a non-discriminatory and non-stigmatising” name for the virus. (BBC)

Invenshure launched an oncology focused biotech company, eyeing a $30 million funding round. The Minneapolis-based medical incubator announced that it launched MEKanistic Therapeutics, a biotechnology company developing oncology treatments that shrink tumors with less toxicity associated with current drugs on the market. (The Business Journals)

A single-payer healthcare system would have saved more lives during the pandemic for less money, a study found. From the start of the pandemic through mid-March 2022, universal healthcare could have saved more than 338,000 lives from COVID-19 as well as$105.6 billion in healthcare costs associated with hospitalizations from the disease. (Esquire)

‘1619 Project’ examined why Black Americans ‘live sicker and die quicker.’ Author Linda Villarosa argues that bias in the healthcare system and the “weathering” affect of living in a racist society are taking a serious toll on African Americans. (NPR)